SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-04-003118
Filing Date
2004-08-09
Accepted
2004-08-09 16:54:55
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS w99812e10vq.htm 10-Q 475757
2 WILLIAM SPENGLER EMPLOYMENT AGREEMENT w99812exv10w41.htm EX-10.41 17187
3 MANUFACTURING & SUPPLY AGREEMENT, DATED JUNE 17,2004 w99812exv10w42.htm EX-10.42 233875
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 w99812exv31w1.htm EX-31.1 6357
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 w99812exv31w2.htm EX-31.2 6371
6 CERTIFICATION OF CEO PURSUANT TO SECTION 906 w99812exv32w1.htm EX-32.1 2585
7 CERTIFICATION OF CFO PURSUANT TO SECTION 906 w99812exv32w2.htm EX-32.2 2582
  Complete submission text file 0000950133-04-003118.txt   747003
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 04961996
SIC: 2834 Pharmaceutical Preparations